SENSITIZATION OF THE BODY IN CHILDREN WITH CHRONIC RECURRENT URTICARIA
DOI:
https://doi.org/10.5281/zenodo.14684249Abstract
The urgency of the problem of chronic urticaria in children is due to the heterogeneity of etiological factors, age-related features of the immunopathological mechanisms of development and course [4,8,9,11,13,14,18]. According to clinical recommendations: urticaria in children [3] and international recommendations [1], urticaria that persists or recurs for more than 6 weeks is considered chronic urticaria. Among children with recurrent urticaria, atopy is detected in 33% of patients.
References
Ким Х. Дж., Ли М.Г. Холинергическая крапивница: нечто большее, чем простая индуцируемая крапивница. Australas J Dermatol. 2017; 58: e193–8.
Федеральные клинические рекомендации по диагностике и лечению крапивницы», Российская ассоциация аллергологов и клинических иммунологов. 2013, пересмотр 2015.
Хаку Г., Софиану-Кацулис А., Перкин М.Р., Лэк Г. Клинические особенности и естественный анамнез физической крапивницы у детей. Иммунол от аллергии у педиатров. 2008;19:363–6.
Athens J.C., Gilchrest H., Richard C. et al. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1)receptor. Eur J Pharmacol 2002; 449: 229–237.
Bobomuratov TA, AA Samadov. Changes in the gastrointestinal tract in the treatment of glucocorticosteroids used in children with nephrotic syndrome: results of a retrospective study. World Bulletin of Public Health 11, 54-57
Bobomuratov TA, SK Rasulov, ZA Dzhurayeva. Nutritional support with products of fruit origin in prevention of micronutrients deficiency in the" motherchild" system. - International Journal of Pharmaceutical Research …, 2020
Bobomuratov, T.A., Karimova, N.A., Tursunbayev, A.K., Nurmatova, N.F. Complications from the cardiovascular system in children who have had COVID-19. E3S Web of Conferences. 2023, 381, 01092
Dustbabaeva, N.D., Irsaliyeva, F.Kh., Nurmatova, N.F., ... Aydarova, N.P., Akhmedov ., K.S. IL17A rs2275913 gene polymorphism in uzbek ethnic group and its linkage with development of allergic rhinitis. Russian Journal of Immunology., 2020, 23(4), P. 443–448.
Irsalieva, F.Kh., Dustbabaeva, N.D., Kamalov, Z.S., ... Nurmatova, N.F., Akhmedov, Zh.Kh. IL17A rs2275913 Polymorphism and features of immunological parameters in patients with persistent allergic rhinitis during allergen-specific immunotherapy. Russian Journal of Immunology. 2020, 23(4), P. 449–460/
Kamide R., Niimura M., Ueda H. et al. Clinical evaluation of ketotifen for chronic urticaria: multicenter doubleblind comparative study with clemastine. Ann Allergy 1989; 62: 322–325.
Kaplan A., Ledford D., Ashby M. et al. Omalizumab in chronic idiopathic/spontaneous urticaria patients symptomatic despite standard combination therapy. J Allergy Clin Immunol 2013; 132: 101–109.
Kessel A., Toubi E. Low-dose cyclosporine is a good option for severe chronic urticaria. Allergy Clin Immunol 2009; 123: 970.
Maurer M, Rosen K, Hsie HJ et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. New Engl J Med 2013; 368: 924–935.
Maurer M., Altrichter S., Bieber T. et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J Allergy Clin Immunol 2011; 128: 202–209.
Metz M., Scholz E., Ferrán M. et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010; 104 (1): 86–92.
Nurmatova, N.F., Mirsalikhova, N.Kh., Asilbekova, M.А., ... Dustbabaeva, N.D., Akhmedov, J.Kh. Body sensitization to various antigens in children with chronic hepatitis b and concomitant giardiasis. Russian Journal of Immunology., 2020, 23(4), страницы 493–498.
Zuberbier T., Aberer W., Asero R. et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2014; 69 (7): e1–29.
Zuberbier T., Aberer W., Asero R. et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69: 868–887.
